DOLINA--docking based on a local induced-fit algorithm: application toward small-molecule binding to nuclear
1Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. martin.smiesko@unibas.ch
Journal of Chemical Information and Modeling
|June 4, 2013
Summary
The Dolina software accurately predicts ligand poses by incorporating protein flexibility and pharmacophore matching. It successfully docked small molecules to nuclear receptors, achieving high accuracy for binding site predictions.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Traditional docking methods often use rigid protocols, limiting accuracy.
- Protein flexibility, particularly local induced-fit, is crucial for understanding ligand binding.
- Nuclear receptors have buried binding sites where induced-fit is significant, especially for antagonists.
Purpose of the Study:
- To introduce and evaluate the Dolina docking software.
- To assess Dolina's ability to model protein flexibility and predict ligand poses accurately.
- To demonstrate Dolina's performance on nuclear receptor systems.
Main Methods:
- Dolina employs pharmacophore matching for pose generation and models induced-fit via side-chain rearrangement.
- Ligand flexibility is handled by screening a pool of low-energy conformers.
- Computational efficiency is achieved through residue grouping and side-chain conformer clustering.
Main Results:
- Dolina was tested on three nuclear receptors using 18 crystal structures.
- Accurate ligand poses (within 2.0 Å RMSD) were generated in 91% of cases.
- The correct pose was ranked first in 28% and within the top five in 76% of docking experiments.
Conclusions:
- Dolina effectively models local induced-fit in protein binding sites.
- The software demonstrates high accuracy in predicting ligand poses for nuclear receptors.
- Dolina is a valuable, freely available tool for academic research in drug discovery.
Related Concept Videos
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Nuclear Localization Signals and Import
Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of 2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...

